Table 1.

Use of medications for COVID-19-specific treatment

	Yes, % (n)	No, % (n)	Medication not available, % (n)	Medication available but not approved for children with COVID-19, % (n)	Medication available, not approved for COVID-19, % (n)
Steroids	75.6% (53)	21.6% (15)	1.4% (1)	1.4% (1)	0% (0)
Antivirals
Remdesivir	48.6% (34)	34.3% (24)	12.9% (9)	2.9% (2)	1.3% (1)
Nirmatrelvir + ritonavir	7.1% (5)	64.3% (45)	18.6% (13)	10% (7)	0% (0)
Molnupiravir	7.1% (5)	65.7% (46)	17.1% (12)	10% (7)	0% (0)
Monoclonals
Casirivimab/imdevimab	11.4% (8)	65.7% (46)	17.1% (12)	4.3% (3)	1.4% (1)
Regdanvimab	0% (0)	72.3% (51)	21.4% (15)	4.3% (3)	1.4% (1)
Sotrovimab	25.7% (18)	50% (35)	22.3% (16)	1.4% (1)	0% (0)
Tixagevimab/cilgavimab	4.3% (3)	67.1% (47)	27.1% (19)	1.4% (1)	0% (0)